These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 28921916)
21. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Miao JW; Liu LJ; Huang J Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843 [TBL] [Abstract][Full Text] [Related]
22. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro. Pang X; Zhang Y; Zhang S Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879 [TBL] [Abstract][Full Text] [Related]
23. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung. Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022 [TBL] [Abstract][Full Text] [Related]
24. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence. Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259 [TBL] [Abstract][Full Text] [Related]
25. S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Moriyama-Kita M; Endo Y; Yonemura Y; Heizmann CW; Miyamori H; Sato H; Yamamoto E; Sasaki T Cancer Lett; 2005 Dec; 230(2):211-8. PubMed ID: 16297707 [TBL] [Abstract][Full Text] [Related]
26. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation. Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209 [TBL] [Abstract][Full Text] [Related]
27. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. Oida Y; Yamazaki H; Tobita K; Mukai M; Ohtani Y; Miyazaki N; Abe Y; Imaizumi T; Makuuchi H; Ueyama Y; Nakamura M Oncol Rep; 2006 Sep; 16(3):457-63. PubMed ID: 16865243 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of S100A4 as a biomarker of metastasis and recurrence in oral squamous cell carcinoma. Natarajan J; Hunter K; Mutalik VS; Radhakrishnan R J Appl Oral Sci; 2014; 22(5):426-33. PubMed ID: 25466476 [TBL] [Abstract][Full Text] [Related]
29. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409 [TBL] [Abstract][Full Text] [Related]
30. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling. Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044 [TBL] [Abstract][Full Text] [Related]
31. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Li Y; Wang W; Wang W; Yang R; Wang T; Su T; Weng D; Tao T; Li W; Ma D; Wang S Gynecol Oncol; 2012 Jan; 124(1):112-8. PubMed ID: 22018873 [TBL] [Abstract][Full Text] [Related]
32. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer. Huang W; Zhu S; Liu Q; Li C; Li L Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215 [TBL] [Abstract][Full Text] [Related]
33. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH. Gründker C; Bauerschmitz G; Schubert A; Emons G Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123 [TBL] [Abstract][Full Text] [Related]
34. LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter. Liu Y; Wang Y; Chen C; Zhang J; Qian W; Dong Y; Liu Z; Zhang X; Wang X; Zhang Z; Shi X; Wu S Oncotarget; 2017 Feb; 8(7):11329-11342. PubMed ID: 27894088 [TBL] [Abstract][Full Text] [Related]
35. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma. Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520 [TBL] [Abstract][Full Text] [Related]
36. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma. Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533 [TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of osteopontin and E-cadherin indicates radiation resistance and poor prognosis for patients with cervical carcinoma. Huang X; Qian Y; Wu H; Xie X; Zhou Q; Wang Y; Kuang W; Shen L; Li K; Su J; Shen L; Chen X J Histochem Cytochem; 2015 Feb; 63(2):88-98. PubMed ID: 25380749 [TBL] [Abstract][Full Text] [Related]
38. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma. Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084 [TBL] [Abstract][Full Text] [Related]
39. Expression of E-cadherin and vimentin in oral squamous cell carcinoma. Zhou J; Tao D; Xu Q; Gao Z; Tang D Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832 [TBL] [Abstract][Full Text] [Related]
40. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers. Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]